Business and Economy

Business and Economy Latest News

Pfizer to acquire sickle cell drugmaker GBT for $5 bn
Pfizer to acquire sickle cell drugmaker GBT for $5 bn
by  AFP

American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion. Bourla said the merger will help "accelerate innovation for the sickle cell disease community and bring these treatments to patients as quickly as possible."

Energy

Money

Industry

Technology

Economy